Narendranath Reddy Ganampet
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Narendranath Reddy Ganampet has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Mihirkumar P. Parmar
Gujarat Medical Education and Research Society
2 shared publications Vishal Venugopal
Bhaarath Medical College and Hospital, Chennai
2 shared publications- Adil Sarvar Mohammed
Department of Internal Medicine, Central Michigan University, Saginaw, Mi 48602, USA
1 shared publication - Aditi Kishor Bhanushali
Department of Cardiovascular Radiology, Mayo Clinic, Rochester, MN
1 shared publication - Alaknanda Behera
Department of Anesthesia, Beth Israel Deaconess Medical Center, Boston, MA, USA
1 shared publication - Babu Vishva
Department of Pathology, JIPMER, Pondicherry, India
1 shared publication
Latest Publications
- 13 February 2026
- Published by Elsevier in The American Journal of the Medical Sciences
- Vol. 371 (6) , 592-594
Impact of prior bariatric surgery on in-hospital outcomes of Takotsubo syndrome in patients with obesity: A nationwide analysis
- 13 February 2026
- Published by Elsevier in The American Journal of the Medical Sciences
- Vol. 371 (6) , 592-594
Impact of prior bariatric surgery on in-hospital outcomes of Takotsubo syndrome in patients with obesity: A nationwide analysis
- Open Access
- 21 September 2023
- Published by Springer Nature in Research Square
Long-Term Effects of Treatment Modalities on Metabolic Health, Fertility Outcomes, and Cardiovascular Risks in Lean Women with Polycystic Ovary Syndrome (PCOS): A Systematic Review
Oligomenorrhea with different degrees of follicular and adrenal hyperandrogenism are the hallmarks of the condition of polycystic ovary syndrome (PCOS). For some of the women in their reproductive years, this endocrine illness is incredibly prevalent and comprises a variety of disorders. There are a set of symptoms, such as hirsutism, acne, and insulin resistance, for identifying the characteristics of PCOS. Various treatment modalities have been opted for over the years for the treatment and management of this condition, among which metformin and flutamide are the most prevalent, along with lifestyle modifications as prevalent recommendations to patients. Weight management for obese patients is the most challenging aspect of PCOS management. Still, similar findings are found in women with lean physiology or a normal BMI, indicating that PCOS symptoms prevail and occur irrespective of the BMI, but obese or overweight women face more problems. We determined the long-term effects of treatment modalities on PCOS symptoms and their improvement. Metformin was reported to primarily increase the blood levels of glucose as well as BMI. Blood pressure was also maintained among various researchers, and DHEAS levels were also altered along with serum sex hormone-binding globulin in the plasma of patients undergoing treatments specific for PCOS patients with a normal BMI or lean PCOS. Further studies with more extensive parameters being employed need to be conducted for the determination of the exact mechanism and cause of the disease to ease the treatment process.
- 21 September 2023
- Published by Springer Nature in Research Square
Open AccessLong-Term Effects of Treatment Modalities on Metabolic Health, Fertility Outcomes, and Cardiovascular Risks in Lean Women with Polycystic Ovary Syndrome (PCOS): A Systematic Review
Oligomenorrhea with different degrees of follicular and adrenal hyperandrogenism are the hallmarks of the condition of polycystic ovary syndrome (PCOS). For some of the women in their reproductive years, this endocrine illness is incredibly prevalent and comprises a variety of disorders. There are a set of symptoms, such as hirsutism, acne, and insulin resistance, for identifying the characteristics of PCOS. Various treatment modalities have been opted for over the years for the treatment and management of this condition, among which metformin and flutamide are the most prevalent, along with lifestyle modifications as prevalent recommendations to patients. Weight management for obese patients is the most challenging aspect of PCOS management. Still, similar findings are found in women with lean physiology or a normal BMI, indicating that PCOS symptoms prevail and occur irrespective of the BMI, but obese or overweight women face more problems. We determined the long-term effects of treatment modalities on PCOS symptoms and their improvement. Metformin was reported to primarily increase the blood levels of glucose as well as BMI. Blood pressure was also maintained among various researchers, and DHEAS levels were also altered along with serum sex hormone-binding globulin in the plasma of patients undergoing treatments specific for PCOS patients with a normal BMI or lean PCOS. Further studies with more extensive parameters being employed need to be conducted for the determination of the exact mechanism and cause of the disease to ease the treatment process.
- Open Access
- 19 September 2023
- Published by Springer Nature in Research Square
Genetic Variants Affecting Insulin Signaling Pathways and Risk of Diabetes: A Comprehensive Systematic Review
Purpose The complicated condition known as type 2 diabetes mellitus (T2DM) has a diverse genetic and environment-related cause. MIM125853 is among the heterogeneous diseases that can also be characterized as a multifactorial disorder of glucose metabolism with genetic susceptibility of an anomaly in the insulin pathway. We conducted the review with aim to assess the genetic variants affecting the insulin pathway as well as evaluate the risk of diabetes in association with genetic variants. Methods We used literature of 13 researches that met the inclusion criteria after the process of selection and analyzation. Our analysis included 59,593 participants in total with a gender distribution of 48% males (n = 24,591) and 52% females (n = 35,002). Result Gene variants such as PPARG, SLC30A8, KCNJ11, TCF7L2 and many others plays a pivotal role in the development of type-II diabetes as well as optimal functioning of insulin metabolic pathway for glucose metabolism and distribution with circulation. Conclusion KCNJ11 regulates insulin release in collaboration with other genes including ABCC8, KAPN10, IRS1 and TCF7L2. Reduced mutual expression of these kinds of genes could contribute to DM susceptibility. However, it is still unknown how precisely the combination of these genes’ functions in the control of insulin secretion.
- 19 September 2023
- Published by Springer Nature in Research Square
Open AccessGenetic Variants Affecting Insulin Signaling Pathways and Risk of Diabetes: A Comprehensive Systematic Review
Purpose The complicated condition known as type 2 diabetes mellitus (T2DM) has a diverse genetic and environment-related cause. MIM125853 is among the heterogeneous diseases that can also be characterized as a multifactorial disorder of glucose metabolism with genetic susceptibility of an anomaly in the insulin pathway. We conducted the review with aim to assess the genetic variants affecting the insulin pathway as well as evaluate the risk of diabetes in association with genetic variants. Methods We used literature of 13 researches that met the inclusion criteria after the process of selection and analyzation. Our analysis included 59,593 participants in total with a gender distribution of 48% males (n = 24,591) and 52% females (n = 35,002). Result Gene variants such as PPARG, SLC30A8, KCNJ11, TCF7L2 and many others plays a pivotal role in the development of type-II diabetes as well as optimal functioning of insulin metabolic pathway for glucose metabolism and distribution with circulation. Conclusion KCNJ11 regulates insulin release in collaboration with other genes including ABCC8, KAPN10, IRS1 and TCF7L2. Reduced mutual expression of these kinds of genes could contribute to DM susceptibility. However, it is still unknown how precisely the combination of these genes’ functions in the control of insulin secretion.